1 advisories in effect for 7 regions in the area
See the complete list
Benjamin Diamond, M.D., a hematologist-oncologist who specializes in multiple myeloma at Sylvester Comprehensive Cancer Center, explains what multiple myeloma is, and how patients, like Debbie Thibos, are thriving thanks to targeted therapies specific to their disease.
Researchers at the Sylvester Comprehensive Cancer Center now have a greater understanding into why a deadly form of brain cancer is so hard to fight.
Tracy Crane, Ph.D., Director of Lifestyle Medicine, Prevention, and Digital Health at Sylvester Comprehensive Cancer Center, explains how lifestyle medicine, like diet and exercise, can benefit cancer survivors. A local breast cancer survivor says Sylvester’s Believe in You program dramatically changed her life for the better.
Estelamari Rodriguez, M.D., a thoracic oncologist at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System, explains how Sylvester’s lung cancer screening program catches cancers earlier in patients by closely monitoring them with regular CT scans to save more lives.
Nipun Merchant, M.D., Chief of the Division of Surgical Oncology at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System, discusses how breakthrough research underway at Sylvester is bringing promising new therapies to pancreatic cancer patients.
Eli Avisar, M.D., a surgical oncologist specializing in lymphedema at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System, explains how lymphedema, a possible serious complication of breast cancer surgery, can be prevented. Gohar Sargsian, a breast cancer survivor, shares her story.
Mikkael Sekeres, M.D., Chief of the Division of Hematology at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System, discusses blood and bone marrow cancers, and the benefits of joining a clinical trial. Eddie Nurquez, a two-time blood cancer survivor, shares his story.
Warren Alperstein, M.D., a pediatric hematologist-oncologist at Sylvester Comprehensive Cancer Center, discusses the treatment of adolescent and young adult cancers (AYA), and how Sylvester offers a multidisciplinary approach to best treat this special population of patients. Candela Gonzalez Marengo is one of those patients.
Dr. Jose Lutzky, a medical oncologist specialized in advanced skin cancers at Sylvester Comprehensive Cancer Center, explains what melanoma is, who is at risk, and how clinical trials offered at Sylvester are helping patients live longer, healthier lives. Dave Hirschman is one of those patients.
Multiple myeloma is the second most common blood cancer in adults. World-renowned myeloma researcher, Dr. Ola Landgren, is bringing his expertise directly to patients as the new Chief of Sylvester’s myeloma program. He explains how innovative new therapies are prolonging the lives of patients who are thriving like never before. Inas Elattar is one of those patients.
Dr. Estelamari Rodriguez, oncologist/hematologist at Sylvester Comprehensive Cancer Center, discusses recent advancements in lung cancer treatments, helping patients live longer, happier lives.
Rachel Silva-Smith, a genetic counselor with the Department of Genetics at Sylvester Comprehensive Cancer Center, explains what genetic testing is, who is a good candidate, and why certain people should undergo testing.
The Dwoskin Proton Therapy Center opens its doors to patients. The NCI-designated cancer center offers patients proton therapy, an advanced and very precise type of radiation.
Sylvester researchers are partnering with Miami-Dade County to help assess the prevalence of COVID-19 throughout the county with a new program known as SPARK-C, the Surveillance Program Assessing Risk and Knowledge of Coronavirus.
Dr. Jamie Merchan, director of Phase I clinical trials at Sylvester Comprehensive Cancer Center, discusses the expansion of Sylvester’s Phase I clinical research program through designation from the National Cancer Institute, and the benefits of participating in ongoing clinical research studies that make new drugs available to patients with cancer.